Q1 Earnings Forecast for MariMed Issued By Ventum Cap Mkts

MariMed Inc. (OTCMKTS:MRMD) – Stock analysts at Ventum Cap Mkts issued their Q1 2025 earnings per share (EPS) estimates for MariMed in a research note issued on Thursday, March 6th. Ventum Cap Mkts analyst A. Semple anticipates that the company will earn ($0.01) per share for the quarter. Ventum Cap Mkts also issued estimates for MariMed’s Q2 2025 earnings at ($0.01) EPS, Q3 2025 earnings at $0.00 EPS and Q4 2025 earnings at $0.00 EPS.

MariMed Price Performance

Shares of MRMD stock opened at $0.11 on Monday. The company has a market cap of $41.70 million, a P/E ratio of -2.73 and a beta of 2.70. The company has a debt-to-equity ratio of 1.01, a current ratio of 1.55 and a quick ratio of 0.73. The stock’s 50-day moving average is $0.12 and its 200 day moving average is $0.15. MariMed has a 1-year low of $0.10 and a 1-year high of $0.34.

MariMed (OTCMKTS:MRMD) last released its quarterly earnings data on Wednesday, March 5th. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.01). The firm had revenue of $39.00 million for the quarter, compared to the consensus estimate of $42.00 million. MariMed had a negative net margin of 10.97% and a negative return on equity of 2.75%.

MariMed Company Profile

MariMed Inc engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand.